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Evidence That a Hemoglobin Adduct
Used for Dosimetry of 4-(Methyl-
nitrosamino)-1-(3-pyridyl)-1-butanone
Is a Carboxylic Ester
by Steven G. Carmella,' Shashi S. Kagan,' and
Stephen S. HechtI
Hemoglobinadductsofthecarcinogenictobacco-specific nitrosamine4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
(NNK) release4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) upon mildbaseoracidhydrolysis. HPB has beendetected in
hydrolysates ofhemoglobin from smokers and snuffdippers and has been proposed asadosimeterofexposure to and
metabolicactivationofNNKinpeopleexposedtotobaccoproducts. Inthisstudy, labelingexperimentswerecarriedout
with["'O]NaOHthat provide strongevidencethattheglobinadductthat releasesHPB uponhydrolysis is acarboxylic
ester. Globinwasisolatedfromratstreatedwith[5-3HINNK. ThisglobinwasreactedwithNaCNBH3,folowedbyhydrolysis
at roomtemperature with02NNaOH. Analysisoftheproductsdemonstratedthe presenceof4-hydroxy-1-(3-pyridyl)-
1-butanol, butnotHPB. TheseresultsdemonstratethattheadductinglobinhasafreecarbonylgroupandisnotaSchiff
base. Thissequenceofreactionswasthencarriedoutwith[1OJNaOH underconditions that wereshowntoresultin in-
corporation of "SO if nucleophilic displacement at C4 had occurred. Analysis by GC-MS of the 4-hydroxy-l-
(3-pyridyl)-1-butanol formed inthisexperimentdemonstratedthattherewas noincorporationof"O Theseresultsare
consistent onlywiththehydrolysisofan esterbyaBAc2 mechanism. Therefore, the adductreleasingHPBuponmild base
hydrolysis must be a 4-(3-pyridyl)-4oxobutyl ester ofaspartate, glutamate, or aterminal carboxylate. Futhersupport
for this conclusion was obtained by investigating the chemistry of a model ester, a-methyl-3-4-(3-pyridyl)-
4-xobutyl-N-carbobenzyloxy-L-aspartate. Thehydrolysis propertiesofthiscompoundweresimilartothoseoftheHPB-
releasing henwglobin adduct.
Introduction
When rats ormice aretreatedwiththecarcinogenic tobacco-
specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK), hemoglobin adducts are formed (1-3). Mild
basehydrolysis ofthishemoglobinreleases20-40% ofthebound
material as4-hydroxy-1-(3-pyridyl)-1-butanone (HPB). Release
of HPB from human hemoglobin has been suggested as a
dosimeter ofhuman exposure to, and metabolic activation of,
NNK as well as a related nitrosamine, N'-nitrosonomicotine.
Levels ofHPB released fromhemoglobin havebeenquantified
in humans by GC-MS (4).
Figure 1 illustrates the postulated mechanism of NNK-
hemoglobinadductformation. Enzymatichydroxylationofthe
methyl carbon yields a-hydroxymethyl-NNK (compound 3 in
Fig. 1), which isunstableandspontaneously decomnposes to for-
maldehyde and 4-(3-pyridyl)-4-oxobutyl diazohydroxide (com-
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pound4inFig. 1). Thisintermediatereactswithanucleophilic
siteinhemoglobin toproduceanadductthatreleases HPBupon
hydrolysis withNaOH orHCl undermildconditions. Previous
studieshaveprovidedsupportforthismechanism. Thesestudies
have shown that the adduct is covalently bound to globin (3).
a-Acetoxy-NNK (NNKOAc; compound 2 in Fig. 1), a stable
precursor to a-hydroxymethyl-NNK, formed the same adduct
uponinjectionintomice(3). Incontrast, HPBdidnotreactwith
hemoglobin in vitro and did not produce HPB-releasing
hemoglobin adducts when injected into mice (3).
Anearlierstudy showedthatcysteineisnotasiteofadductfor-
mation inthehemoglobinofrats treated with NNK(5). In this
paper, wedescribeexperiments with[180]NaOHthat strongly
supportthehypothesis thatthe HPB-releasing hemoglobin ad-
duct is acarboxylic ester.
Results and Discussion
Ourinitialgoalwastodeterminewhetherornottheadducthad
afreecarbonyl group. Thecyclic intermediate (compound6 in
Fig. 2) is formedduringthesolvolysisofNNKOAcandcouldbe
involved in adduct formation, producing an adduct without aCARMELL4 ETAL.
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FIGURE 1. Metabolic activation ofNNK to globin adducts that release HPB upon hydrolysis.
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carbonyl group(6). Thisinformationwasnecessarybefore 180-
labeling experiments couldbecarriedout, sincethey wouldbe
confoundedbyexchangeifafreecarbonyl groupwerepresent.
Globin was isolated from rats treated with [5-3HINNK. The
globin wasallowedtoreactwithNaCNBH3atpH6-7, conditions
that do not release HPB. The NaCNBH3-treated globin was
dialyzed, thenhydrolyzed with mildbase. Thehydrolysatewas
analyzed by HPLC. About 20% ofthe radioactivity co-eluted
with4-hydroxy-l-(3-pyridyl)-1-butanol (compound7 inFig. 2).
HPBwasnotdetectedinthissample. Whenthissamplewasbase
treatedwithoutpriorNaCNBH3treatment, 25% oftheradioac-
tivity wasreleased asHPB. Theseresultsdemonstratethatafree
carbonyl group is present in the HPB-releasing adduct, which
therefore mustbea4-(3-pyridyl)-4-oxobutyl adductratherthan
acyclic one. TheresultsalsoshowedthattheHPB-releasingad-
duct is not a Schiffbase.
The next series of experiments involved hydrolysis with
['80]H20. Theseexperimentswerecarriedoutonglobinthathad
been treatedwith NaCNBH3, inorderto avoid exchangeofthe
carbonyl oxygen. Iftheadductwereacarboxylicester, wewould
expect hydrolysis by theBAC2 mechanism and no incorporation
of180intothediol (compound7inFig.2). Hydrolysisofanether
wouldnotoccurunderthemildconditionsthatweareusing. Any
otheradduct, betweenC4oftheoxobutylgroupand, forexam-
ple, histidine or lysine ofglobin, would hydrolyze with incor-
poration of 180 into thediol.
Conditions for this experiment were developed using two
model compounds, thehydroxyester(compound8inFig. 2)and
the tosylate (compound 9 in Fig. 2). Compound 8 (Fig. 2) was
a model foracarboxylic esteradduct. As expected, hydrolysis
ofthiscompoundwith['80]NaOHyieldedcompound 7(Fig. 2),
with an M+1 peakof168(relative intensity, 100) initschemical
ionization-MS; nopeakatm/e 170wasdetected. Thus,therewas
no incorporation oflabel into the diol (compound7 in Fig. 2).
Compound 9 (Fig. 2) was a model foradducts that would have
undergone anucleophilic substitutionreactionresulting inincor-
poration of180. Hydrolysis with ['8O]NaOHproducedmainly
3-vinylpyridine (95%). Theminorproduct(compound 10inFig.
2) contained > 85% 80. Wealsoattemptedtopreparehydroxy
tosylate (compound 11 inFig. 2)asamodel, butitwasunstable
and its solvolysis producedexclusively thefuran (compound 12
in Fig. 2). These control experimentsestablishedthatourcon-
ditions were adequate to detect incorporation of ISO upon
hydrolysis ofthe globin adduct.
Globin from rats treated with [5-3H]NNK was reacted with
NaCNBH3, dialyzed, and hydrolyzed with ['8O]NaOH in
['80]H20. Diol (compound7 inFig. 2) was isolatedbyHPLC,
silylated, andanalyzedbyGC-MS. Themolecularionofthebis
trimethylsilyletherofthediol ism/e311. Theratioofm/e311 to
m/e 313 was the same in the material isolated fromglobinas in
the standard. Thus, there was no detectable incorporation of
10, and theadduct mustbe acarboxylic ester.
Furtherevidencewasobtainedbysynthesisofthemodelaspar-
tate ester(compound 13 in Fig. 2). Hydrolysis was carried out
undermildbasicoracidicconditions. ReleaseofHPBwascom-
pleteinbase, whereasonly6% wasreleasedinacid. Therelease
of HPB from globin of NNK-treated rats under the same
hydrolysisconditions wascompleteinbase, accountingfor 19.6%
ofthe radioactivity boundto globin. In acid, only 2.3% ofthe
boundradioactivity wasreleasedasHPB(5); thus, theextentof
hydrolysis was 12% as great as that observed in base.
ThecarboxylicesteradductofNNKinglobincouldbeformed
byreactionofdiazohydroxide (compound4inFig. 1) withaspar-
tate, glutamate, ortheterminalcarboxylgroupsofglobin. Are-
centstudyhasused l-amino-2,3-propanediol tolocateoneofthe
benzo[a]pyrenediol epoxidecarboxylicesteradducts ataspar-
tate47ofthe(xchainofhumanhemoglobin(7). Wearecurrently
exploringthisapproachforidentifyingtheacidsinvolved infor-
mation ofthe HPB-releasing adduct.
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